Agile Therapeutics
AGRX
$0.40
Share price
0.00%
Change (1 day)
-93.94%
Change (1 year)
Categories
Agile Therapeutics (AGRX) Fails to deliver data
Key failure to deliver metrics for Agile Therapeutics :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.09 M
- Last 3 months FTD volume: $0.44 M
- Last year FTD volume: $1.42 M
Failures to deliver for Agile Therapeutics (AGRX) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Agile Therapeutics (AGRX) - since 2023
Volume in USD (price x number of shares), data since 2023Agile Therapeutics (AGRX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.44 M | -55.36% |
| 2023 | $0.98 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.14 B | $0.60 B | 🇺🇸 USA |
 Pfizer PFE | $31.87 M | $0.32 B | 🇺🇸 USA |
 Merck MRK | $8.48 M | $0.18 B | 🇺🇸 USA |
 TherapeuticsMD TXMD | $0.04 M | $0.11 M | 🇺🇸 USA |
 Antares Pharma ATRS | N/A | $5.91 M | 🇺🇸 USA |